Login to Your Account



Biopharma sector calls for novel antibody drugs amid health care efforts

By Cornelia Zou
Staff Writer

Friday, June 20, 2014
TIANJIN, China – Among the country's plan to boost its biopharmaceutical sector, a focus on developing antibodies is likely to characterize the development of the industry over the next few years, said officials and executives during an annual gathering.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription